The Role of Interleukin-6 in the Pathogenesis, Prognosis and Treatment of Severe COVID-19.

Giannakodimos, Ilias; Gkountana, Georgia-Vasiliki; Lykouras, Dimosthenis; Karkoulias, Kiriakos; Tsakas, Sotiris

Giannakodimos, Ilias; Gkountana, Georgia-Vasiliki; Lykouras, Dimosthenis; Karkoulias, Kiriakos; Tsakas, Sotiris.

Afiliación

Giannakodimos I; Department of Respiratory Medicine, University Hospital of Patras, Rio Patras, Greece.
Gkountana GV; Lab of Biology, Department of Biology, University of Patras, Rio Patras, Greece.
Lykouras D; Department of Respiratory Medicine, University Hospital of Patras, Rio Patras, Greece.
Karkoulias K; Department of Respiratory Medicine, University Hospital of Patras, Rio Patras, Greece.
Tsakas S; Lab of Biology, Department of Biology, University of Patras, Rio Patras, Greece.

Curr Med Chem ; 28(26): 5328-5338, 2021.

Article en En | MEDLINE | ID: mdl-33297909

Asunto(s)

COVID-19; Interleucina-6; COVID-19/inmunología; Humanos; Interleucina-6/inmunología; Filogenia; Pronóstico

Palabras clave

COVID-19; Coronavirus.; Interleukin-6; Pandemic; SARS-CoV-2; Tocilizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interleucina-6 / COVID-19 Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Curr Med Chem Asunto de la revista: QUIMICA Año: 2021 Tipo del documento: Article País de afiliación: Grecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google